Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report

Biocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder and CEO of Bicara Therapeutics. She holds advanced degrees and has prior industry experience. Biocon is also undergoing structural changes. The company focuses on biosimilars and integrating artificial intelligence. Other leadership transitions are also in progress across group companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7IeS5jn
via IFTTT